Autoreactive T cells from a type I diabetic recognize multiple class II products

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Type I diabetes is an autoimmune disease characterized by T-cell mediated destruction of pancreatic beta cells.
• Genetic predisposition, particularly certain human leukocyte antigen (HLA) haplotypes, significantly increases type I diabetes risk.
• Autoreactive T cells play a crucial role in the autoimmune process, but their specific targets remain incompletely understood.

Purpose of the Study:

• To investigate the specificity of autoreactive T cells in a child with newly diagnosed type I diabetes.
• To identify the human leukocyte antigen (MHC class II) molecules that present self-peptides to autoreactive T cells.
• To explore the hypothesis that autoreactive T cells can recognize peptides derived from self-MHC molecules.

Main Methods:

• Mononuclear cells from a type I diabetes patient were stimulated in vitro with insulin, IL-2, and IL-4.
• Isolation and characterization of CD4+ T-cell clones.
• Analysis of T-cell recognition of autologous B cells presenting different class II MHC molecules.

Main Results:

• All isolated T-cell clones were autoreactive, recognizing autologous B cells without exogenous antigen.
• T-cell clones showed skewed recognition of class II MHC antigens, with some recognizing peptides derived from DR beta chains presented by other DR beta chains.
• Several clones were stimulated by DPw4 molecules, and only one recognized a DR3 haplotype product.

Conclusions:

• Autoreactive T cells in type I diabetes can recognize self-peptides presented by various class II MHC molecules, not just DR beta 1.
• A subset of these autoreactive T cells may recognize peptides derived from self-MHC molecules, offering a new perspective on autoimmunity.
• These findings support the hypothesis that autoreactive T cells recognize autologous peptides in association with MHC molecules.